Table 3

ICIQ-UI SF score reduction after 3 months’ treatment; incontinent users who responded to the 3-month follow-up

Score at baseline, mean (SD)Score at 3-month follow-up, mean (SD)Difference
(95% CI)
P value*
All incontinent users (n=2163)8.11 (3.87)6.80 (3.97)1.31 (1.19 to 1.44)<0.001
Symptom severity
 Slight (n=689)4.18 (0.74)3.94 (2.54)0.24 (0.06 to 0.42)0.010
 Moderate (n=1145)8.50 (1.97)7.09 (3.10)1.41 (1.24 to 1.59)<0.001
 Severe/very severe (n=329)14.98 (1.93)11.76 (3.80)3.23 (2.85 to 3.61)<0.001
Type of incontinence
 Stress incontinence (n=1196)7.66 (3.70)6.38 (3.78)1.28 (1.11 to 1.45)<0.001
 Urgency incontinence (n=263)7.59 (3.88)6.26 (4.14)1.33 (0.95 to 1.71)<0.001
 Mixed incontinence (n=632)9.20 (3.96)7.86 (4.02)1.34 (1.09 to 1.58)<0.001
 Other (n=72)7.89 (4.01)6.26 (4.14)1.63 (0.76 to 2.50)<0.001
  • *Analysed with paired t-test.

  • ICIQ-UI SF, International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form.